Novartis Investigative Site

Rishikesh, Uttarakhand 249203

0 studies enrolling now · 3 studies all time

What they study most

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia, Primary Immune Thrombocytopenia, Primary Immune Thrombocytopenia (ITP)

Studies at this site

• A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids — Running, not enrolling
• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling
• A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) — Running, not enrolling